ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Abstract Number: 0321
    M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort
  • Abstract Number: 0510
    MACE and VTE Across Upadacitinib Clinical Trial Programs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
  • Abstract Number: 0261
    Machine Learning and Computational Pathology Can Reveal Synovial Pathotypes in Mice and Humans
  • Abstract Number: 0336
    Machine Learning Approach for the Prediction of Lupus Nephritis Renal Flares Using Polygenic Risk Score and Electronic Health Record
  • Abstract Number: 1607
    Machine Learning Identifies Biomarker of Non-Response to Methotrexate in Rheumatoid Arthritis
  • Abstract Number: 1400
    Machine Learning Identifies Molecular Phenotypes That Predict Incident Cardiovascular Disease in Patients with Rheumatoid Arthritis
  • Abstract Number: 1404
    Machine Learning Model to Accurately Identify Rheumatoid Arthritis Patients Using Raw Electronic Health Record Data
  • Abstract Number: 2233
    Machine Learning Uncovers Novel mRNAs Expressed in Fibromyalgia
  • Abstract Number: 0609
    Macrophage Response to MAA Modified Fibrinogen in the Presence of Peptidyl Arginine Deiminase Inhibitor
  • Abstract Number: 1527
    Maintained Complete B Cell Depletion Is Associated with Rituximab Efficacy in Connective Tissue Disorder Interstitial Lung Disease
  • Abstract Number: 0306
    Maintenance of Disease Activity and Treatment Persistence in Patients with Rheumatoid Arthritis Who Switched from Combination to TNF Inhibitor Monotherapy: Results from the Rheumatology Informatics System for Effectiveness (RISE) Registry
  • Abstract Number: 1646
    Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs Initiation in Patients with Rheumatoid Arthritis
  • Abstract Number: 2032
    Major Salivary Gland Ultrasound and Elastography for Assessment of Disease Activity in Patients of Primary Sjögren’s Syndrome
  • Abstract Number: 1984
    Malignancies Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a National Study: RELATION Study
  • Abstract Number: 0277
    Malignancy Events in the Filgotinib Rheumatoid Arthritis and Ulcerative Colitis Clinical Development Programs
  • Abstract Number: 0292
    Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
  • Abstract Number: 1683
    Malondialdehyde-Acetaldehyde (MAA) Modified Matrix Gla Protein (MGP) Increases Citrullination by Human Macrophages
  • Abstract Number: 0831
    Management of Hepatic Sarcoidosis, a Retrospective Analysis of Patients at a University Hospital
  • Abstract Number: 1484
    Management of the Heightened Risk for Clinical Events from Atherosclerotic Cardiovascular Disease (ASCVD) in an Established Cohort of Lupus Erythematosus Patients
  • Abstract Number: 0212
    Managing Psoriatic Arthritis: Patients’ Views and Attitudes to Using an Online Wellness Program
  • Abstract Number: 0326
    Mapping Anti-Mitochondrial Antibodies over Time in a Lupus Inception Cohort
  • Abstract Number: 0748
    Mapping Long COVID-19 Patient Journeys for Rheumatic Disease Patients
  • Abstract Number: 1160
    Mapping Spondyloarthritis Susceptibility Loci in B10.RIII Mice
  • Abstract Number: 0491
    Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis
  • Abstract Number: 1749
    Mass Spectrometry-Based HLA Peptidomics Analysis Reveals Both Expected and Novel Citrullinated Antigen Targets in Rheumatoid Arthritis
  • Abstract Number: 1642
    Mast Cells May Explain Sex Differences in Osteoarthritis Pain
  • Abstract Number: 1942
    Maybe Silent: Spine Disease in Chronic Recurrent Multifocal Osteomyelitis, Clinical Features, Risk Factors, and Red Flags
  • Abstract Number: 1270
    MDHAQ/RAPID3 Is a Feasible Tool to Estimate High Comorbid Fatigue and Residual Fatigue in Rheumatoid Arthritis Patients
  • Abstract Number: 0054
    MDSCs in Inflammatory Joints of SKG Mice Suppress T Cells and Differentiate into Osteoclasts
  • Abstract Number: 1697
    Measurements of Specific Activation Through the Lectin -or Classical Pathway of Complement in Patients with SLE
  • Abstract Number: 2066
    Measuring Sexual Dysfunction as an Indicator of Frailty in Systemic Lupus Erythematosus Population
  • Abstract Number: 1094
    Mechanical Loading-induced BHLHE40 Promotes Inflammatory Arthritis
  • Abstract Number: 0606
    Mechanism of Joint-Specific Homeobox D10 Regulation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
  • Abstract Number: 0733
    Median Patient Global Assessment Varies Far More According to FAST4 (fibromyalgia Assessment Screening Tool) and MDS2 (MDHAQ Depression Screen) on a Single MDHAQ (multidimensional Health Assessment Questionnaire) Than According to Primary Diagnosis
  • Abstract Number: 0551
    Medical Cannabis Use by Rheumatology Patients According to Inflammatory versus Non-Inflammatory Condition
  • Abstract Number: 1115
    Medication Co-pay Modifies Treatment Adherence in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2063
    Medication Cost Concerns and Disparities in Patient-reported Outcomes Among a Multiethnic Cohort of Patients with Lupus
  • Abstract Number: 1947
    Medication Use in Childhood Sjogren Disease
  • Abstract Number: 1570
    Memory CD4+T Cell Signature Is Associated with Unfavorable Prognosis in IgG4-related Disease: Risk Stratification by Machine-learning
  • Abstract Number: 1377
    Mental Health Screening in Juvenile Myositis: Preliminary Analysis of a Multicenter Pilot Study
  • Abstract Number: 2078
    Mesangial Lupus Nephritis: Long Term Outcomes
  • Abstract Number: 1007
    Metabolic Disorders and Abnormal Dietary Patterns and Their Association with Psoriatic Arthritis Activity: The Dietary Intervention in PsA (DIPSA) Study
  • Abstract Number: 0320
    Metabolomics in Systemic Lupus Erythematosus and Pregnancy – A Prospective Observational Longitudinal Study
  • Abstract Number: 2242
    Metabolomics-based Identification of Metabolic Dysfunction in Inclusion Body Myositis
  • Abstract Number: 2040
    Metformin Improves Objective Measures of Dry Eyes and Focus Score in Sjögren′s Disease: A Retrospective Observational Study
  • Abstract Number: 0747
    Methotrexate and Hydroxychloroquine Used as Single Agent May Diminish Breakthrough Infection After COVID-19 Vaccination
  • Abstract Number: 0926
    Methotrexate Polyglutamates Exposure – Response Modelling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate
  • Abstract Number: 0915
    Methotrexate Therapy Results in Disparate Methotrexate Polyglutamate Profiles in Peripheral Blood Mononuclear Cells Compared with Erythrocytes
  • Abstract Number: 1137
    MHC Class I Polypeptide-Related Sequence a Variant Predicts Real-World Response to Anti-TNF Therapy
  • Abstract Number: 1991
    Mice Do Not Develop CIA: Knocking out of Kv1.3 Renders CD4+TEMCells Resistant to Activation
  • Abstract Number: 0028
    Microenvironmental Stiffness Modulates Macrophage Responsiveness and Communication with Mesenchymal Stem Cells
  • Abstract Number: 1557
    Microvascular Involvement in Behçet’s Disease: Study of Nailfold Capillaroscopy in Patients from a National Referral Center
  • Abstract Number: 0170
    Minimal Clinically Important Difference in Myositis Response Criteria
  • Abstract Number: 2131
    Minimal Disease Activity Response Patterns in Bio-Naïve Patients Treated with Guselkumab: A Machine Learning Analysis
  • Abstract Number: 1017
    Minimal Important Difference (MID), Minimal Detectable Change (MDC), and Disease Activity Thresholds for Two Novel Composite Instruments (3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of Three Phase 3 Studies
  • Abstract Number: 0252
    Mitochondrial Content in Skeletal Muscle of Individuals with Rheumatoid Arthritis Is Associated with Physical Activity Level
  • Abstract Number: 0041
    Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors
  • Abstract Number: 1510
    Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries
  • Abstract Number: 1560
    Modulation of NKG2D Expression on NK, NKT and CD8+ T Lymphocytes by in Vitro Treatments of Immune Cells from Patients with Behçet Disease
  • Abstract Number: 0975
    Modulation of T, B, and Innate Cell-Associated Pharmacodynamic Biomarkers in a Phase 3 Trial of Anifrolumab in Moderate to Severe SLE
  • Abstract Number: 0646
    Modulation of Type I IFN Production and Regulatory T Cells by the PKGI/ROCK Signaling Pathway
  • Abstract Number: 1680
    Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis
  • Abstract Number: 1428
    Molecular and Clinical Profiling of Rheumatoid Arthritis Patients Predicts the Response to Rituximab
  • Abstract Number: 0558
    Molecular Interplay Between Mammalian Target of Rapamycin (mTOR) and the YAP Pathway Mediates Rheumatoid Arthritis Synovial Fibroblast Activation
  • Abstract Number: 1139
    Molecular Pathways Identified from Risk Alleles Identify Mechanistic Differences in Systemic Lupus Erythematosus Patients of East Asian and European Ancestry
  • Abstract Number: 0590
    Molecular Profiling of Normal Human Synovium Reveals Striking Impact of Adipocytes and Homeostatic Cortisol Signaling
  • Abstract Number: 0233
    Monoarthritis Virtual Teaching Module for Rheumatology Learners
  • Abstract Number: 0248
    Monocyte Chemoattractant Protein-1, Vascular Cell Adhesion Protein-1 and Asymmetric Dimethylarginine as Potential Biomarkers of Interstitial Lung Disease Associated with RA
  • Abstract Number: 1118
    Monocyte Transcriptomic Analysis Uncovers Heterogeneous Gene Expression Profiles in Systemic Lupus Erythematous (SLE) with and Without Subclinical Atherosclerosis
  • Abstract Number: 1950
    Morbidities Associated with Serious Infections in Patients with Rheumatoid Arthritis
  • Abstract Number: 2011
    More Meticulously Following Treat-to-target in RA Does Not Lead to Less Radiographic Progression: A Longitudinal Analysis in BIODAM
  • Abstract Number: 1775
    More Than Half of Patients with Osteoarthritis Have Positive Screening for Fibromyalgia And/or Depression, Feasibly Assessed in Routine Care on Indices Within a Single MDHAQ (multidimensional Health Assessment Questionnaire)
  • Abstract Number: 1778
    More Than Half of RA Patients with a Lifetime History of Mood Disorders or Anxious and Depressed During COVID-19 Pandemic
  • Abstract Number: 1953
    Mortality in Rheumatoid Arthritis: Changing Causes and Predictive Factors. Study of a Cohort Followed Prospectively
  • Abstract Number: 1845
    Mortality Prognostic Factors of Critically Ill Patients with Systemic Autoimmune Diseases Admitted in a Medical Intensive Care Unit: A 20-year Cohort Study
  • Abstract Number: 0381
    Most Disease Outcome Measures but Not ASDAS Are Influenced by Gender in Patients with Axial SpA: Results from ASAS-PerSpA
  • Abstract Number: 1541
    MRI Digital Artery Volume Index (DAVIX) Predicts Future Digital Ulcers and Disease Progression in Systemic Sclerosis
  • Abstract Number: 0493
    MRI Is Superior to Ultrasound of Supraaortic Arteries in Detecting Giant Cell Arteritis – Experience of a Single Center
  • Abstract Number: 2257
    MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis
  • Abstract Number: 2182
    mRNA Vaccine Against Fibroblast Activation Protein Ameliorates Murine Models of Inflammatory Arthritis
  • Abstract Number: 0004
    mTORC1 Drives the Spectrum of Pathology in Systemic JIA and Macrophage Activation Syndrome
  • Abstract Number: 2183
    mTORC2 Contributes to Murine Systemic Autoimmunity
  • Abstract Number: 1221
    Multi-Center Validation of Cell-Bound Complement Activation Products and a Multianalyte Assay Panel Distinguishing Systemic Lupus Erythematosus from Primary Fibromyalgia
  • Abstract Number: 1922
    Multi-Joint Osteoarthritis Phenotypes by Race/Ethnicity and Sex: Preliminary Descriptive Data from the Johnston County Health Study
  • Abstract Number: 2213
    Multi-omic Analysis of Macrophage Activation Syndrome Associated with sJIA Reveals a Potential Role of Type I Interferons in the Expansion of Cycling T Cells
  • Abstract Number: 0342
    Multi-Parametric Interrogation of the Systemic Lupus Erythematosus (SLE) Immunome Reveals Multiple Derangements
  • Abstract Number: 1506
    Multimorbidity in Psoriasis as a Risk Factor for Psoriatic Arthritis: A Population-Based Study
  • Abstract Number: 1190
    Multimorbidity in Systemic Sclerosis: Burden and Trends in Prevalence from an Incident Population-based Cohort (1980-2018)
  • Abstract Number: 1589
    Multiple Switching Between the Biosimilar Adalimumab PF-06410293 (Abrilada™) and Reference Adalimumab (Humira®)in Combination with Methotrexate in Patients with Moderately to Severely Active Rheumatoid Arthritis
  • Abstract Number: 0335
    Multiplexed Mass Cytometry of Cutaneous Lupus Erythematosus and Dermatomyositis Skin: An In-depth B Cell Directed Immunoprofile
  • Abstract Number: 0178
    Muscle Fibres Play a Critical Role in Therapeutic Response of Myositis to Glucocorticoids Through Polarisation of the Inflammatory Infiltrate by a Paracrine Mechanism
  • Abstract Number: 0581
    Mutants Improving Stability Enhance the Potency of Treg-Selective IL-2 Mutein for the Treatment of Autoimmune Disorders
  • Abstract Number: 1741
    Mutated Nod2 Controls T Cell Function and Promotes Uveitis in a Blau Syndrome Mouse Model
  • Abstract Number: 0519
    Myeloablation Followed by Hematopoietic Stem Cell Transplantation Leads to Long-term Normalization of Systemic Sclerosis Molecular Signatures
  • Abstract Number: 0575
    Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment with Denosumab or Zoledronic Acid for Osteoporosis
  • Abstract Number: 1615
    Myocardial Infarction in Patients with Systemic Vasculitis and Population Controls: Characteristics and Overall Mortality
  • Abstract Number: 1398
    Myokine Myostatin Is a Novel Predictor of One-year Radiographic Progression in Patients with Rheumatoid Arthritis
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology